Related Experiment Videos
Risperidone: a novel antipsychotic with many "atypical" properties?
P Stathis1, K Antoniou, Z Papadopoulou-Daifotis
1Department of Experimental Pharmacology, University of Athens Medical School, Greece.
Psychopharmacology
|October 1, 1996
Summary
This study compared risperidone and haloperidol effects on brain neurotransmitters. Chronic risperidone uniquely increased dopamine and serotonin activity in the prefrontal cortex, unlike haloperidol.
Area of Science:
- Neuropharmacology
- Neuroscience
- Psychiatry
Background:
- Risperidone (Ris) and haloperidol (Hal) are antipsychotics with mixed receptor antagonist profiles.
- Understanding their differential effects on neurotransmitter systems is crucial for treatment optimization.
Purpose of the Study:
- To investigate the acute and chronic effects of risperidone versus haloperidol on dopaminergic and serotoninergic activity.
- To compare their neurochemical profiles in specific rat brain regions: prefrontal cortex (Pfc), striatum (Str), dorsal striatum (StrD), and nucleus accumbens (Acb).
Main Methods:
- Administration of risperidone and haloperidol (acute and chronic) to rats.
- Measurement of dopamine (DA) and serotonin (5-HT) turnover rates in Pfc, Str, StrD, and Acb.
Main Results:
- Acutely, haloperidol increased DA turnover more than risperidone in the dorsal striatum.
- Chronically, risperidone, but not haloperidol, continued to increase DA turnover in the dorsal striatum.
- Chronic risperidone also increased DA and 5-HT turnover in the prefrontal cortex, whereas haloperidol did not.
Conclusions:
- Risperidone and haloperidol exhibit distinct neurochemical profiles, particularly with chronic administration.
- Risperidone demonstrates sustained effects on dopamine and serotonin in the prefrontal cortex, differentiating it from haloperidol.